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Abstract
AIMS: The primary objective of this study was to identify if symptom presentation
expressed over the course of an influenza-like illness (ILI) can predict virus type by use
of unsupervised machine learning. The secondary objective was to describe clinical
characteristics of strain specific coronavirus. Finally, examine the psychometric
properties of the Canadian Acute Respiratory Illness and Flu Scale (CARIFS).
BACKGROUND: ILI outbreaks have been a significant source of non-battle injury
among military personnel. Many different viruses cause ILI, and it is difficult to
determine which virus is causing the illness. Recent studies have examined the etiology
and epidemiology of ILIs. Other studies have examined influenza virus symptom
severity either a dichotomous or liner-sum analysis. No studies to the researcher’s
knowledge have examined ILI symptoms through an unsupervised learning analysis, and
few studies have examined self-reported outpatient ILI reported symptoms over an
extended time frame.
METHODS: This is a secondary analysis of data collected over a four year period by the
Acute Respiratory Infection Consortium (ARIC), from an otherwise healthy military
population. The symptom data was captured on visit days and by a symptom diary
patients filled out at home using a symptom severity instrument designed for this study.
FINDINGS: Clustering by unsupervised machine learning was unable to predict virus
type based on physical symptom presentation over the course of ILI. It did identify
patient attributes, like sex and age that caused patients to experience symptoms
differently. Additionally, clinical similarities and differences were noted between the
four common human coronavirus strains. The strain HKU1 tended to have higher

systemic symptom scores and higher gastrointestinal symptom severity score over the
course of illness when compared to the other strains. Finally, the psychometric properties
of CARIFS revealed many strengths and limitations for its use in research. The CARIFS
should be reexamined using current knowledge of symptom management to increase the
validity of the instrument.
IMPLICATIONS: The results demonstrated how individuals experience physical
symptoms differently making it difficult to predict the viral strain causing ILI. Future
research should focus on the development of symptom instruments using the theoretical
underpinnings of the symptom management theory.
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Chapter 1
Introduction
Overview
Through history, influenza virus subtypes have been responsible for pandemics
across the world (United States Department of Health and Human Services, n.d.; Rogers,
2010; Simonsen et al., 2013). In 2009, a military humanitarian mission was cancelled
due to an influenza outbreak on the main ship (BBC News, 2009). Many viruses cause
influenza-like illnesses such as, influenza A and B, coronavirus, rhinovirus, adenovirus,
and they tend to be highly contagious. The symptom presentation of the viruses can vary
with the illness, but they also have many common overlapping symptoms. For instance,
respiratory syncytial virus (RSV) tends to cause more severe lower respiratory systems,
while rhinovirus has a greater effect on the upper respiratory system; but, they share
some common symptoms such as cough (Walsh & Hall, 2010; Turner, 2010). The
presentation ILI symptoms varies based on virus; therefore, it is possible to predict the
type of virus affecting an individual.
Background and Significance
Theoretical Framework
The Symptom Management Theory (SMT) is the theoretical framework that
guided this study. The concept of SMT was initially introduced as the Symptom
Management Conceptual Model in 1994 by Larson and colleagues. This model focused
on identifying the underlying cause of a symptom and managing the total symptom
experience, instead of focusing on the cause of a symptom alone. The model was later
1

revised in 2001 by Dodd and colleagues as more of a dynamic process where symptoms
experienced and changes in strategy needed to occur over time. In 2008 the framework
was renamed Symptom Management Theory, and was introduced as a middle range
theory by Humphreys and colleagues. An underlying principle in the development of
SMT is the nurses’ involvement. Larson and colleagues stressed the importance for
nurses to take the lead in developing a symptom model because they are more involved in
the management of patient symptoms. The Symptom Management Theory has a
bidirectional conceptual relationship among symptom experience, symptom management,
and symptom outcomes (Landers, 2014).
Approximately twenty years ago symptom research was focused on a single
symptom, such as pain, or known associated symptoms as stomach pain and diarrhea.
With the development of the Symptom Management Conceptual Model leading to the
SMT, symptoms are now looked at as a multidimensional process relying on not only one
symptom experienced, but taking into account other factors, such as environment, health
and illness, and different types of symptom outcomes (Dodd et al, 2001). Dodd and
colleagues (2001) defined symptoms as subjective experiences echoing individual
changes in sensations and biopsychosocial and cognitive functioning. Many recent
studies have utilized SMT to guide their symptom research in the fields of HIV, cancer,
and constipation focusing on symptom experience with self-care outcomes. A study by
Dodd, Cho, Cooper, and Miaskowski (2010) was supported by the concepts of SMT, and
reported symptoms are experienced in clusters. The study examined specific symptom
clusters in women receiving chemotherapy with symptom severity assessed at different
2

time points over the course of treatment. Lenz, Rugh, Milligna, Gift, & Suppe (1997)
indicated symptoms have a reciprocal link between physiologic, psychologic, and
situational factors, and multiple symptoms are multiplicative, not additive.
Symptom Management Theory is divided into three key components: symptom
experience, symptom management strategies, and patient outcomes (see figure 1). All
three components of SMT are within the three domains of nursing science: person,
environment, and health and illness. For the purpose of this research study, the SMT
component of interest was symptom experience, specifically perception and evaluation of
symptoms. Symptom experience is defined as the intensity, misery, and occurrence of
symptoms as they are produced (Armstrong, 2003). According to SMT, symptom
experience is evaluated within the three domains of nursing science (Humphreys et al,
2014). With the strict inclusion/exclusion criteria of the data collected for the research
study, the researcher made the assumption that the three domains of nursing science were
equal across the population.
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FIGURE 1- Theoretical framework for study: Symptom Management Theory
From “Nursing theory and concept development or analysis: Advancing the science of
symptom management,” by Dodd, M.J., Janson, S., Facione, N., Faucett, J., Froelicher,
E.S., Humphreys, J…, Taylor, D., 2001, Journal of Advanced Nursing, 33(5), 668-676.
Copyright 2008 by John Wiley and Sons.

Influenza-like illness
Currently, based on symptomatology, there are a multitude of different definitions
as to what classifies an illness as influenza or influenza-like. The World Health
Organization (WHO) defines influenza-like illness as an acute respiratory infection with
onset in the last 10 days with cough and measured fever, but they do not provide a clear
definition on the diagnosis of influenza (World Health Organization, 2014). The
International Classification of Health Problems in Primary Care (ICHPP-2) states the
4

diagnosis of influenza can be made if six of the nine influenza-like symptoms occur:
sudden onset, cough, chills, fever, weakness, headache, myalgia, no physical signs other
than redness of nasal mucous and throat, and influenza close contacts (Govaert, Dinant,
Aretz & Knottnerus, 1998). The Center of Disease Control and Prevention (CDC)
defines influenza-like illness as a fever, cough and/or sore throat with the presence of a
sick contact or potential epidemic, and leaves the diagnosis of influenza vague, based on
symptoms alone (Center for Disease Control and Prevention, 2015).
In the literature, a variety of diagnostic criteria exists to classify an illness as
influenza-like. Common themes to the diagnosis of influenza-like illness include fever,
sudden onset, cough, and potential for other symptoms typically related to influenza. For
the purpose of this study, influenza-like illness is defined as: a fever over 100.4

℉ and

respiratory symptoms (cough, sputum production, shortness of breath, chest pain) and/or
sore throat.
Viruses associated with ILI
There are over 200 different viruses that produce influenza-like symptoms
(Eccles, 2005). A recent systematic review of studies examining the concept of
influenza-like illness identified people who presented with ILI symptoms, and the
common viruses experienced were: adenovirus, coronavirus, influenza A/B, human
metapneumovirus, parainfluenza, picorna virus, respiratory syncytial virus (RSV), and
rhinovirus (Thomas, 2014). Research continues to grow in the area of being able to
distinguish viruses based on patient symptomatology (Puzelli et al., 2009). The
frequency of the virus type causing influenza-like illness depends on the seasonality of
5

data collected, location, and age group. The most common viruses to cause ILI
symptoms are: adenovirus, rhinovirus, influenza A/B, coronavirus, RSV, and human
metapneumovirus (Puzelli et al., 2009; Thomas, 2014).
Adenoviruses are common with over 100 identified across all species with the
infection being self-limiting. Adenoviruses are known to cause respiratory tract
infection, ocular disease, and gastrointestinal tract disease (Rhee & Barouch, 2010).
Rhinoviruses account for approximately 40% of all cases of upper respiratory infection.
Rhinovirus infections are typically classified as the ‘common cold,’ causing symptoms
mostly concentrated in the upper respiratory tract (Turner, 2010).
The influenza virus is divided into types, A and B. Influenza type A is known to
cause global pandemics with high mortality in the younger population, while influenza B
typically does not result in pandemics and occurs in older adults or high-risk population.
Clinical manifestations of influenza are: fever, sore throat, cough, and malaise, and there
is a vaccine developed yearly to help prevent the illness (Treanor, 2010).
Respiratory syncytial virus (RSV) infections tend to attack the lower respiratory
system, and is the most frequent cause of bronchiolitis in infancy and influenza-like
symptoms in the adult population. The clinical manifestations of RSV differ by the age
group infected with young children experiencing bronchiolitis, pneumonia, and some
upper respiratory tract symptoms, while older children and adults present mostly lower
respiratory tract symptoms and pneumonia (Walsh & Hall, 2010). Human
metapneumovirus (hMPV) is a newly discovered virus, first described in 2001, and
causes severe lower respiratory tract disease, ranking second to RSV in children. The
6

clinical manifestations are similar to RSV and pneumonia with the most common
symptoms associated with it being fever, nasal congestion, and cough (Falsey, 2010).
Coronaviruses are known to cause upper respiratory symptoms in humans, and
cause 15%-35% of the influenza-like illnesses reported in clinics (McIntosh & Perlman,
2010). The severe acute respiratory syndrome (SARS) and Middle East respiratory
syndrome (MERS) viruses have been the focus of many coronavirus studies, while the
common human sub-types have not. The four common types of coronavirus are known
to cause upper respiratory symptoms similar to influenza, but few studies have examined
the characteristics of the different strains (McIntosh & Perlman, 2010).
ILI Symptoms
When people experience influenza-like illness symptoms, it is common for them
to diagnose themselves with a ‘cold’ or the ‘flu’ (Eccles, 2005). ILI symptom experience
varies, but the most common reported symptoms include: fever, cough, rhinorrhea, and
sore throat. Because symptom experience is subjective, it is difficult to determine which
virus is the cause of ILI without laboratory testing.
The progression of symptom experience differs from person to person, but most
literature agrees ILI typically starts with a fever and progresses to upper respiratory tract
symptoms (Eccles, 2005; Tyrrell, Cohen, & Schlarb, 1993). There are some ILI viruses
that cause systemic and gastrointestinal symptoms in addition to the respiratory tract
symptoms. Although people with ILI characterize the symptom experience as the worst
part of the illness, these symptoms may actually help them overcome the illness with the
release of more cytokines (Eccles, 2005).
7

Symptom severity experience is subjective, and can build off previous illness
knowledge. Due to the variety of symptoms people experience with influenza-like
illnesses, it is difficult to advise people when to seek treatment with symptoms because
they may be conflated with other ailments. People have reported not taking the diagnosis
influenza seriously, and continued their daily life activities, while other strongly
recommended seeing a healthcare provider as soon as possible and were worried about
being a vector for the virus (Jutel & Banister, 2013).
ILI Symptom Measurement
The scale used for capturing symptom severity of ILI for this project came from
the Acute Respiratory Infection Consortium (ARIC). ARIC used the scale in their
longitudinal influenza-like illness research, specifically in the military population (Chen
et al, 2015). During the development of ARIC’s protocol, the researchers could only
identify one validated ILI symptom severity tool, the Canadian Acute Respiratory Illness
and Flu Scale, but it was specifically designed for children (Jacobs et al, 2000).
Therefore, ARIC developed their own symptom severity scale utilizing aspects from four
similar non-validated symptom severity scales they termed: Hayden I, Hayden II, Keech,
and ICCSQ (Devoulyte & Sullivan, 2003; Hayden, Fritz, Lobo, Alvord, Strober, &
Straus, 1998; Keech, Scott, & Ryan, 1998; Treanor et al., 2000).
The scale created by ARIC has 20 symptoms which people with ILI rank on a
four point scale, and are broken down into four subscales: systemic, upper respiratory,
lower respiratory, and gastrointestinal. The 20 question symptom scale is written in
layman’s terms, such as ‘earache’, not ‘otalgia’, so that it would be filled out more
8

accurately. The four point symptom severity scale is similar to the Hayden I and II scale
where 0=none, 1=mild, 2=moderate, and 3= severe. Recently the ARIC group has
developed and validated a new ILI symptom measurement instrument, Flu-PRO, utilizing
the symptom data from this project (Powers et al., 2013; Powers et al, 2016).
ILI and the Military
A person’s age, physical state, and current immunological status can have an
effect on ILI symptoms experienced. Many studies focus on ILI symptomatology in the
older adult or young child population, as they are considered the most vulnerable.
However, historically military members have been vulnerable to influenza outbreaks with
ILI being the leading cause of outpatient reported illness in the military (Gray, Callahan,
Hawksworth, Fisher, & Gaydos, 1999).
The United States military population is unique since they are generally young,
healthy individuals. Active duty military members must have constant readiness to
protect and serve the United States, and must be continuously aware of their health and
fitness state; but, they are a high-risk group for ILI due to their occupation and other
factors, such as living arrangements.
Some members of the United States military live in barracks or in close-living
conditions, which can increase the transmit ability of a virus. Some may also live with
their family who work with the outside community where a virus outbreak could be
occurring. Additionally, active duty military members tend to have an increase in
psychological stress and difficulty maintaining personnel hygiene depending on where
they are stationed for service (Gray et al., 1999; Kocik et al. 2014; Padin et al., 2014).
9

Other Factors influencing ILI symptoms
Immunologically, the response to a viral infection differs based on a person’s
gender due to genetic and hormonal differences. The WHO examined the effects of an
influenza virus infection on gender globally, and noted a difference in symptom
experience and mortality rates in some regions of the world (World Health Organization,
2010). In the Netherlands a study compared day to day symptom experience in males to
females. Overall females had higher summed symptom scores and greater symptom
reporting when compared to the males (Gijsbers van Wijk, Huisman, & Kolk, 1999).
People who smoke or are former smokers are known to have a decrease in their
lung function due to the components of cigarette smoke, including carcinogens. During
an outbreak of influenza A in 1979, an Israeli military unit was studied to identify the
effects of smoking on disease severity and susceptibility on female recruits. The data
showed women recruits who smoked reported more severe influenza-like illness and high
rates of contraction of illness (Kark & Lebiush, 1981). Another study examined the
effects of smoking on U.S. Army recruits in 1982 with results showing those who
smoked were more likely to be seen for an upper respiratory tract infection (Blake, Abell,
& Stanlet, 1988).
Body mass index (BMI) is a measure of body fat based on a person’s weight and
height for the adult population. Many obesity-related factors have potential to affect the
outcome of infectious diseases such as, obstructive sleep apnea, decreased pulmonary
volumes, decreased wound healing, and dysregulated immune responses in the lung
(Huttunen & Syrjanen, 2013). Several studies found high BMI values are a risk factor for
10

illness severity during the 2009 influenza A pandemic (Louie et al., 2011; Yu et al.,
2011).
Studies have shown a person’s ethnicity can influence symptom presentation in
many diseases, including viral illnesses (Corley, D.A., Kubo, A., & Zhao, W., 2007;
Pattermore, Asher, Harrison, Mitchell, Rea, & Stewart, 1989; O’Connor et al, 2003).
CDC reports indicated self-reported ILI were lower in Hispanics and non-Hispanic blacks
and higher in American Indians during the 2009 influenza pandemic. Additionally,
minorities had higher rates of hospitalizations when compared to non-Hispanic whites
(Dee et al, 2011). A pediatric population-based surveillance study of several ILI viruses
noted patients who were Hispanic and non-Hispanic black had higher rates of
hospitalizations (Iwane et al, 2004).
Statement of the Problem
The review of literature identifies the need for further understanding of ILI
symptom experience, especially in the young adult/ military population. Studies
predicting virus types based on patient reported ILI symptoms limited. Most of the
studies predicting virus type focus on the patient having or not having influenza without
consideration of the other viral types. Additionally, there is a gap in knowledge
regarding symptom experience in the military population, which is unique compared to
the general population.
Another gap in knowledge identified was classifying the symptom experience in
people experiencing the more common forms of human coronavirus. A majority of the
literature currently focuses on the more severe forms, SARS and MERS. Further
11

examining the common forms of coronavirus may lead to better understanding of future
mutated forms of the virus.
Purpose of the Study
The purpose of the study is to explore and characterize ILI and symptom
experience in a military population, and determine if symptom presentation can predict
virus type. This study is a secondary analysis of data collected from an observational,
longitudinal military cohort study designed to determine the etiology, epidemiology, and
clinical characteristics of ILI. Secondary data analysis studies are useful because they
allow researchers to examine data in other ways than originally intended with bigger
numbers for analysis, but can also be limiting because further data collection from
participants involved is difficult to complete. This design method is appropriate for the
purpose of this study because the use of already collected data will provide more
variables for analysis and larger numbers for a more thorough analysis.
Specific Aims of the Three Papers
This dissertation consists of three manuscripts written for publication in various
journals. The manuscripts are formatted per the guidelines of the journal for potential
publication. The specific aims for each paper are:
1. Identify if symptom presentation over the course of influenza-like illness (ILI)
can predict virus type in an otherwise healthy military population using
unsupervised machine learning; Identify sub-populations with similar
symptom experience.

12

2. Describe the strain specific clinical characteristics of coronavirus among an
otherwise healthy US military population.
3. Examine the psychometric properties of one of the few validated instruments
examining disease severity of ILI, the Canadian Acute Respiratory Illness and
Flu Scale (CARIFS).
Summary
During the 2014-2015 influenza season, the CDC’s outpatient illness surveillance
reported ILI activity being at or above the baseline measure for 20 weeks, which made it
the longest season for reported ILI activity (Center for Disease Control and Prevention,
2015). Symptom experience is a subjective measure, which makes it difficult to identify
the type of virus that may be causing the symptoms. Utilizing the military database to
analyze ILI symptoms that active duty and their beneficiaries experience will provide the
ability to characterize and understand them.

13
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Chapter 2:
Symptom Experience and Influenza-like Illness in a Military Population
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Abstract
Background
Of over 350,000 samples were collected from the 2012-2013 flu season, only 21% were
positive for an influenza virus. ILI outbreaks are a significant source of non-battle injury
among military personnel and may lead to mission cancellations. Prior studies of
influenza symptom severity used dichotomous or linear sum analysis but few examined
symptoms over the course of the illness. No studies to the researcher’s knowledge have
examined ILI symptoms through an unsupervised machine learning analysis.
Aims
The primary objective is to identify if symptom presentation over the course of influenzalike illness (ILI) can predict virus type in an otherwise healthy population using
unsupervised machine learning. The secondary aim is to identify sub-populations with
similar symptom experience.
Methods
The Acute Respiratory Infection Consortium (ARIC) conducted a prospective
longitudinal study from 2009-2014 to determine the etiology, epidemiology, and clinical
characteristics of ILI. The sample population (n=1590) was healthy active duty military
members, healthy retirees, and their dependents from five US treatment
facilities. Subjects recorded symptoms on days 0, 3, and 7 using a tool designed for this
study. Nasopharyngeal samples were collected for virus identification. This analysis only
includes cases with complete visit data (n=699).
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Unsupervised machine learning algorithm k-means clustering analyzed the data in two
ways. In both approaches, patients were clustered by the individual symptom score for
every visit to capture severity and illness progression. In the first analysis, patients of all
virus types were clustered with patients without a viral diagnosis. The other analyses
clustered patients diagnosed with the most prominent viruses (influenza A, rhinovirus,
and coronavirus) separately.
Results
The primary analysis was unable to predict virus type or differentiate those with and
without a virus based on patient symptom experience using a variety of scoring
approaches. The secondary analyses with rhinovirus (n=101), influenza A (n=107), and
coronavirus (n=51) each yielded at least one symptom cluster with a statistically
significant difference based on non-symptom features using one-way ANOVA or chi
square testing. The clustered rhinovirus data showed the most statistically significant
differences amongst the clusters in the attributes: sex, BMI, age, smoking history, and
military status. The clustered influenza A data showed a statistically significant
difference in clusters based on sex and ethnicity. The clustered coronavirus data only
showed some differences amongst clusters in regards to sex, which was expected as the
data set was well distributed. Overall the patients in the different virus clusters
experienced symptoms differently compared to the total population for virus type.
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Background
The most common cause of illness and visits to healthcare providers in the United
States (US) are influenza-like illnesses (ILI). The annual cost associated with ILI in the
US is estimated to be over 12 billion dollars. An ILI is defined as having an acute
respiratory infection with fever and presence of sick contact, and is typically caused by a
contagious virus (Center for Disease Control and Prevention, 2015; World Health
Organization, 2014). The Center of Disease Control and Prevention (CDC) established a
surveillance network called, U.S. Outpatient Influenza-like Illness Surveillance Network
(ILInet), which continuously monitors ILI in the outpatient setting. The network allows
information about the rate of ILI infections across the US be monitored (Center for
Disease Control and Prevention, 2015).
Historically, there have been several ILIs that reached pandemic levels with the
most notable being the Spanish Flu of 1918, which affected the global population, but in
the US the hardest hit population was the military (Gray, Callahan, Hawksworth, Fisher,
& Gaydos, 1999). During World War I, the US military suffered more deaths from the
influenza outbreak of 1918-1919 than combat casualties. The poor environmental
conditions the service members endured, combined with a delay in enacting quarantine
procedures, led to the high number of infections and morbidity (Byerly, 2010).
Military
Almost one hundred years later, ILI outbreaks still affect military readiness. In
2009 the United States Department of the Navy had to cancel a planned humanitarian
mission to the Pacific because of an outbreak of influenza on the USS Dubuque (BBC
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News, 2009). Although the active duty military population are known to be healthy,
young and active; they are still at higher risk for ILI due to their housing and working
environment (Gray, Callahan, Hawksworth, Fisher, & Gaydos, 1999).
Many enlisted members continue to live in close quarters such as barracks. Some
live off base with their family, but others live in close knit military communities. Most
members share common areas daily, such as the mess hall, gym, or even stair wells.
Additionally, depending on a service members’ duty station, they may experience an
increase in psychological stress and/or difficulty maintaining personal hygiene, therefore,
decreasing their ability to fight off an infection (Gray et al., 1999; Kocik et al. 2014;
Padin et al., 2014). All these situations put the current active duty members at an
increased risk for an ILI outbreak.
ILI is the leading cause of outpatient reported illnesses in the military (Gray,
Callahan, Hawksworth, Fisher, & Gaydos, 1999). Most ILI research studies focus on
population extremes, such as young children or older adults, or those people with
underlying conditions. Most members of the US military do not meet these descriptions,
so it is important to understand how ILIs affect this population due to them having to be
constantly ready to deploy.
Symptom Experience
Symptoms are subjective experiences stimulating changes in a person’s feelings
and biopsychosocial factors; therefore, people’s experience of symptom severity may
vary (Dodd et al, 2001). Several studies have examined the symptom experience of
participants with ILI to predict the diagnosis of influenza, but they did not yield
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satisfactory results (Peltola, Reunanen, Ziegler, Silveinnonen, & Heikkinen, 2005; Puzelli
et al, 2009). The symptoms of cough and fever during the influenza season were found to
be better predictors of influenza, but study limitations are the lack of a uniform method of
symptom measurement.
Biological, psychological, and social factors can contribute to a person’s symptom
experience. Studies have shown a person’s history of smoking can have an effect on ILI
susceptibility and severity most likely stemming from the structural changes in the lungs
caused by the smoke inhalation (Arcavi & Benowitz, 2004; Blake, Abell, & Stanlet,
1988; Kark & Lebiush, 1981). A person’s body mass index (BMI) is a risk factor for
worse illness severity as demonstrated recently with the H1N1 outbreak; people with
higher BMIs tended to have worse symptom severity (Louie et al., 2011; Yu et al., 2011).
Additionally, a Canadian study noted, a positive association between increased BMI and
rates of respiratory hospitalizations during the influenza season (Kwong, Campietelli, &
Rosella, 2011).
Gender can also influence the response of a viral infection due to genetic and
hormonal differences. There is a gender difference between symptom severity and
influenza infection outcome with females having higher morbidly and mortality rates
(World Health Organization, 2010). Gijsbers van Wijk, Huisman, & Kolk (1999) studied
daily symptom experience in males and females, and noted females had a higher summed
symptom scores. A person’s ethnicity can also influence symptom presentation. During
the 2009 H1N1 pandemic, the CDC noted self-reported ILI was lower in Hispanics and
non-Hispanic blacks and higher in American Indians with higher rates of hospitalizations
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for minorities when compared to non-Hispanic whites (Dee et al, 2011). A pediatric
population-based surveillance study of several ILI viruses noted patients who were
Hispanic and non-Hispanic black had higher rates of hospitalizations (Iwane et al,2004).
Unsupervised Machine Learning
Unsupervised machine learning is a process that detects patterns in data with
minimal human guidance. One of the most common approaches to unsupervised learning
is called clustering, wherein samples are grouped together based on similarity. The
resulting clusters can be used for classification, population segmentation, or be further
analyzed for common features. This paper employs a technique called k-means
clustering, which is described below.
K-means clustering (MacQueen, 1967) is one of the simplest, but also one of the
most widely-used and easily understood forms of unsupervised learning. While there are
numerous extensions and improvements to the algorithm, the most basic approach starts
by randomly selecting k points to serve as representative points of each cluster. Then, all
samples in the data set are assigned to one of these points, based on similarity. Next all k
representative points are moved to the mean of all the sample points that were assigned to
them. This process of assigning points to clusters and updating the means of those
clusters is repeated until the points assigned to a mean are unchanged, i.e. the algorithm
has convergence, or a fixed number of reassignments occurs. The value of k in k-means
clustering must be provided by the experimenter and is typically based on domain
knowledge or discovered through experimentation with several values (see figure 1).
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Figure 1: Graphical representation of K means clustering process

This clustering algorithm has been applied to many problem domains such as
image segmentation (Ng et al, 2006), feature learning (Coates, 2012), and user
classification (Lingras, 2004). Some notable medical applications of k-means clustering
include predicting the recurrence of breast cancer (Belciug et al, 2010) and detection of
Alzheimer’s disease (Escudero et al, 2011).
Studies examining patient reported ILI symptoms to predict virus type are limited,
especially related to virus types other than influenza. Most research focuses on the
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influenza virus and symptoms, and not the other common viruses identified as sources of
ILI. The military population is a unique population when compared to the general
population, and there is limited knowledge regarding symptom experience in the military.
Additionally, there are no studies to the authors’ knowledge that utilize unsupervised
machine learning to identify if symptom severity can predict ILI virus type.
Objectives
The primary objective is to identify if symptom presentation over the course of
influenza-like illness (ILI) can predict virus type in an otherwise healthy military
population using unsupervised machine learning. The secondary aim is to identify
subpopulations with similar symptom experience.
Methods
Study Design
A secondary analysis of symptom severity data from a prospective ILI study
conducted by the Acute Respiratory Infection Consortium (ARIC) whose methods for
data collection have previously been reported (Chen et al, 2015). This study received
exempt status approval from the University of San Diego. Below is a summary of the
methods ARIC utilized for its prospective study.
Overview of ARIC study
The ARIC conducted a longitudinal study for the purpose of determining the
etiology, epidemiology, and clinical characteristics of ILI among healthy active and
retired military personnel and their beneficiaries. The study data was collected from
2009-2014 from five US military treatment facilities across the United States. The study
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was approved by the Infectious Disease Institutional Review Board of the Uniformed
Services University of Health Sciences (IDCRP-045), and written informed consent was
obtained prior to data collection.
Population
Patients aged 0-65 years who presented to the clinic within 72 hours of influenzalike illness (ILI) symptoms were included into the study. ARIC defined ILI symptoms as
having a self-reported fever above 100.4F with at least one of the following upper
respiratory symptoms: cough, shortness of breath, chest pain, sputum production, sore
throat). Patients with a history of chronic disease such as, COPD, uncontrolled asthma,
diabetes, immunodeficiency, heart disease, neuromuscular disease, or renal disease were
excluded from the study.
Demographic and patient history data were captured at enrollment.
Nasopharyngeal samples were collected for virus identification analysis. Symptom data
was captured prospectively on visit days 0, 3, 7, 28, and by a take-home seven-day
symptom diary.
Symptom severity and virus identification tools
Clinical symptom severity was captured by a symptom severity instrument
created for this study. The instrument was modified from several ILI symptom severity
instruments, and included rating 20 symptoms. The patients were instructed to rate their
severity on an ordinal scale with 0=none and 3= severe on daily basis in their seven day
symptom journal and at all scheduled study visits. The symptoms on the instrument
were: decrease in appetite, earache, runny nose, eye pain, sore throat, cough, breathing
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difficulty, dizziness, hoarseness, chest pain, muscle ache, sneezing, joint pain, fatigue,
headache, chills, abdominal pain, nausea, vomiting, and diarrhea.
The nasopharyngeal swabs collected were analyzed by multiplex assays (xTAG
Respiratory Viral Panel, Luminex, Austin, TX pr PLEX-ID Viral IC Spectrum, Abbott,
Chicago, IL). The multiplex assays detected the presence of the following viral
respiratory pathogens: influenza A and B, adenovirus, rhinovirus, coronavirus,
respiratory syncytial virus, parainfluenza virus, bocavirus, coxsackievirus/echovirus, and
metapneumovirus.
Sample used in current study
Participants aged 0-65 with complete symptom severity measurements for visits
0, 3, and 7 were included in analysis. Any cases with incomplete symptom severity
measures and/or a co-detection of another respiratory virus were excluded from analysis.
People with bacterial co-infections were not excluded because the study focused on viral
illnesses. Only the symptom visit data, demographic information, and viral diagnosis
were needed for the analyses.
Data Analysis
Descriptive statistics were used to create and analyze the dataset for this study.
Basic demographic information such as, age, sex, geographic location, ethnicity, military
rank, and BMI were analyzed to determine distribution of data.
Primary Objective
All eligible patients were clustered together according to symptom expression on
visit days 0, 3, and 7. The symptoms were analyzed as separate entities, and not grouped
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for a total score or system scores. The distribution of viral diagnosis for each cluster was
then compared to the distribution of the entire population to determine if any of the
resulting clusters represented a specific virus type or group of virus types. Groups that
were different were further analyzed to determine what unique symptom expressions
caused them to cluster together and could potentially be associated with one or more
viruses. Because it was unclear if different viruses may express similarly (and therefore
cluster together) clustering was run with k values ranging from 5 to 10 clusters.
Secondary Objective
Patients were grouped together based on viral diagnosis to correct for symptoms
that may be specific to a particular virus type. Only three viruses, influenza A,
coronavirus, and rhinovirus, had sufficient numbers to perform meaningful clusters. The
patients in each group were clustered on symptom expression, and compared based on
demographic information (sex, military status, age, BMI, smoking, ethnicity) to
determine if any clusters represented how a specific group may experience an
illness. Patients with these viruses were clustered with k set to five for rhinovirus and
influenza A and four for coronavirus due to the smaller sample set for coronavirus.
The distribution of attributes for each cluster were then compared to the
distribution of the entire population for that virus. Groups with different attributes had
Chi square test or one-way ANOVA test performed (based on variable type) to identify if
there were any statistically significant differences between the clustered groups based on
symptom data that caused them to cluster together. If statistical significance was found
in a cluster, Bonferroni post-hoc analyses were performed.
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All statistical analyses were performed using SPSS software, version 22 (IBM
corporation). Clustering was performed with scikit-learn version 0.17.1’s
implementation of K-Means Clustering on Python 2.7.6, with default parameters except
for the number of clusters which were varied as part of the experiments.
Results
Demographics
ARIC had a total of 1590 patients with viral diagnosis data, but over 50% of those
patients had missing symptom data for their visits. For that reason, a subsample of 699
was mined that included only patients who had complete symptom data for visits 0, 3,
and 7. The sample was amended further to exclude patients with viral co-infections to
reduce the possibility of symptom interaction. A total of 645 patients’ data was used for

Figure 2: Sub-sample distribution by virus type

analysis (see fig. 2).

34

Predicting virus type
The goal of the first experiment was to determine if a particular ILI virus has
universal symptom expression among all patients, allowing it to be uniquely identified by
physical symptoms alone. After initial analysis, only the k=7 clustering demonstrated
promising differences (see figure 3). Detailed analysis of this clustering revealed that all
clusters were not significantly different than the population (p > 0.05 for all clusters and
virus types) except for a one cluster (cluster 3, fig. 3) had a statistically significant
difference (p<.000) and coronavirus percentage (17.3%) when compared to the overall
population (7.9%). However, this cluster contained eight total virus types, some with
similar percentages (16.4% influenza A and 14.5% rhinovirus); thus, it would not be very
helpful in an absolute diagnosis. An ideal cluster distribution would be heavily skewed
towards one or two virus types. Overall, this experiment was unable to predict virus type
or differentiate those with and without a virus based on individual patient symptom
experience using a variety of scoring approaches.
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Percentage of Patients With Virus

Figure 3: Distribution of viruses in k=7 clusters
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Symptom Experience
The second experiment attempts to identify if different patient attributes may
cause them to experience a virus differently. For example, people who smoke are more
likely to have compromised lung function; therefore may present with more severe
respiratory symptoms when compared to a non-smoker with the same illness.
There were a total of nine viruses in the data set, but only three had sufficient
numbers to run the analysis: rhinovirus (n=101), influenza A (n=107), and coronavirus
(n=51). The patient attributes examined were: age, military status, BMI, sex, smoking
history, and ethnicity. Each clustering by virus type yielded at least one symptom cluster
with a statistically significant difference based on patient attributes.
Five out of the six attributes in the clustered rhinovirus data had statistically
significant differences (see table 1). Bonferroni post-hoc analyses identified which
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aspects of patients within the clusters were attributing to the differences. Analyses
showed that cluster 2, as seen in table 1, had statistically significant differences in
military rank, more likely a dependent (p<.000), smoking status, non-smoker (p<.01),
BMI, underweight BMI, (p<.000), and age, less than 12 (p<.000). The underweight BMI
was expected with this cluster due to the group being mostly patients under 12; therefore,
it is difficult to use this attribute. Cluster 4 demonstrated statistical significant difference
in sex, more females (p<.000), and cluster 3 had significant statistical difference in
smoking history (p<.000).
Examining the median symptom scores per cluster implies a younger population
(as seen in cluster 2) with rhinovirus do not have as severe of symptoms as adults and
experience eye pain (see table 4); or, females (as seen in cluster 4) present with more
severe upper respiratory symptoms (table 4).
The clustered influenza A data showed a statistically significant difference in
clusters based on sex and military status (see table 2). Bonferroni post hoc analyses
though revealed only cluster 3 had statistical significant difference in sex (p<.000), while
cluster 4 was approaching a statistically significant difference in military status.
Examining the median symptom scores for cluster 3 (see fig. 4), infers females have
lingering coughs and runny noses with initial headache presentation when compared to
the population total.
The clustered coronavirus data only showed a statistically significant difference in
clusters in regards to sex (table 3), but Bonferroni post hoc analysis revealed clusters 3
and 4 were only approaching statistically significant differences. Examining the median
37

scores for the clusters show cluster 4, which was all female, tended to express worse
upper respiratory symptoms, while cluster 3 (mostly males) tended to express worse
systemic scores when compared to the total population (see figure 4).
Table 1: Rhinovirus attributes by cluster
Cluster1
N (%)

Cluster2
N (%)

Cluster3
N (%)

Cluster4
N (%)

Cluster5
N (%)

pa

13
1
63
24

0 ( 0)
0 ( 0)
10(67)
5(33)

12(71)
1 ( 6)
3(18)
1 ( 6)

0 ( 0)
0 ( 0)
21(81)
5(19)

0 ( 0)
0 ( 0)
5(62)
3(38)

1 ( 3)
0 ( 0)
24(68)
10(29)

.000

Sex
Male
Female

65
36

9(60)
6(40)

10(59)
7(41)

19(73)
7(27)

0 ( 0)
8(100)

27(77)
8(23)

.001

Ethnicity
White
Black
Asian
Other

70
13
6
11

9(60)
2(13)
1( 7)
3(20)

11(65)
5(29)
0 ( 0)
1 ( 6)

16(61)
2 ( 8)
4(15)
4(15)

7(87)
1(12)
0 ( 0)
0 ( 0)

27(79)
3 ( 9)
1 ( 3)
3 ( 9)

.369

History of Smoking
Yes
39
No
62

8(53)
7(47)

2(12)
15(88)

18( 6)
8(21)

1(13)
7(87)

10(29)
25(71)

.000

Body Mass Index
<18.5
11
18.5-24.99
25
25-29.99
39
>30
24
missing
2

0 ( 0)
3(20)
7(47)
5(33)
0 ( 0)

9(53)
4(23)
1 ( 6)
2(12)
1 ( 6)

19(73)
7(27)
19(73)
7(27)
0 ( 0)

0 ( 0)
5(63)
2(25)
1(12)
0 ( 0)

1 ( 3)
6(17)
20(57)
7(20)
1 ( 3)

.000

Military Status
Active Duty 74
Dependent 23
Retired
4

11(73)
3(20)
1( 7)

4(2%)
13(77)
0 ( 0)

24(9%)
1 ( 4)
1 ( 4)

6(75)
1(12)
1(13)

29(83)
5(14)
1 ( 3)

.000

Age (yrs)
0-12.9
13-17.9
18-34.9
35-65

Total
N=101
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Table 2: Influenza A attributes by cluster
Total
Cluster1
N=107
N (%)

Cluster2
N (%)

Cluster3
N (%)

Cluster4
N (%)

Cluster5
N (%)

pa

7
1
66
33

1(11)
0 ( 0)
3(33)
5(56)

5(15)
1 ( 3)
18(55)
9(27)

0 ( 0)
0 ( 0)
9(56)
7(44)

0 ( 0)
0 ( 0)
25(78)
7(22)

1 ( 6)
0 ( 0)
11(65)
5(29)

.100

Sex
Male
Female

69
38

3(33)
6(67)

26(79)
7(21)

4(25)
12(75)

25(78)
7(22)

11(65)
6(35)

.000

Ethnicity
White
Black
Asian
Other
Missing

69
22
9
6
1

9(100)
0 ( 0)
0 ( 0)
0 ( 0)
0 ( 0)

18 ( 5)
6(18)
6(18)
2 ( 6)
1 ( 3)

12(75)
3(19)
0 ( 0)
1 ( 6)
0 ( 0)

20(63)
7(22)
3 ( 9)
2 ( 6)
0 ( 0)

10(59)
6(35)
0 ( 0)
1 ( 6)
0 ( 0)

.384

History of Smoking
Yes
35
No
72

3(33)
6(67)

10 ( 3)
23(70)

4(25)
12(75)

11(33)
21(66)

7(41)
10(59)

.898

Body Mass Index
<18.5
11
18.5-24.99 25
25-29.99
39
>30
24
missing
9

0 ( 0)
2(22)
3(34)
2(22)
2(22)

4(12)
10(30)
8(2%)
7(21)
4(1%)

0 ( 0)
3(19)
10(63)
2(12)
1(6)

1 ( 3)
10(31)
5(16)
14(44)
2 ( 6)

1 ( 6)
7(41)
4(24)
5(29)
0 ( 0)

.132

2(22)
6(67)
1(11)

18(54)
11(33)
4(12)

10(63)
5(31)
1 ( 6)

27(84)
4(13)
1 ( 3)

12(71)
4(23)
1 ( 6)

.031

Age (yrs)
0-12.9
13-17.9
18-34.9
35-65

Military Status
Active Duty
Dependent
Retired

74
23
4

39

Table 3: Coronavirus attributes by cluster
Total
N=51

Cluster1
N (%)

Cluster2
N (%)

Cluster3
N (%)

Cluster4
N (%)

pa

0
3
41
7

0 ( 0)
0 ( 0)
11(85)
2(15)

0 ( 0)
0 ( 0)
13(81)
3(19)

0 ( 0)
3(18)
13(76)
1 ( 6)

0 ( 0)
0 ( 0)
4(80)
1(20)

.404

Sex
Male
Female

22
29

7(54)
6(46)

4(25)
12(75)

11(65)
6(35)

0 ( 0)
5(100)

.020

Ethnicity
White
Black
Asian
Other
Missing

30
11
3
6
1

8(61)
2(15)
1 ( 8)
1 (8)
1 ( 8)

9(56)
4(25)
1 ( 6)
2(13)
0 ( 0)

9(53)
4(23)
1 ( 6)
3(18)
0 ( 0)

4(80)
1(20)
0 ( 0)
0 ( 0)
0 ( 0)

.996

History of Smoking
Yes
16
No
35

5(39)
8(61)

6(38)
10(62)

4(24)
13(76)

1(20)
4(80)

.718

Body Mass Index
<18.5
11
18.5-24.99
25
25-29.99
39
>30
24
Missing
9

1 (8)
5(38)
1 ( 8)
6(46)
0 ( 0)

1 ( 6)
8(50)
6(38)
1( 6)
0 ( 0)

0 ( 0)
7(41)
5(29)
4(24)
1 ( 6)

0 ( 0)
1(20)
2(40)
2(40)
0 ( 0)

.132

Military Status
Active Duty 44
Dependent
7
Retired
0

12(92)
1 ( 8)
0 ( 0)

13(81)
3 ( 1)
0 ( 0)

14(82)
3(18)
0 ( 0)

5(100)
0 ( 0)
0 ( 0)

.206

Age (yrs)
0-12.9
13-17.9
18-34.9
35-65

40

Table 4: Change in symptom score amongst clusters against total population
Influenza A

Rhinovirus

CLUSTER 1 2 3 4 5 CLUSTER
DECREASEAPP_D0 -

Coronavirus
1 2 3 4 5 CLUSTER

- DECREASEAPP_D0

DECREASEAPP_D3

DECREASEAPP_D3

DECREASEAPP_D7

DECREASEAPP_D7

SHORTBREATH_D0 -

-

-

- SHORTBREATH_D0

+

SHORTBREATH_D3

+

SHORTBREATH_D7 +

SHORTBREATH_D7
CHEST_PAIN_D0

CHEST_PAIN_D3 +

CHEST_PAIN_D3

CHEST_PAIN_D7

DECREASEAPP_D0

-

DECREASEAPP_D3

-

+

-

- CHILLS_D0

CHILLS_D3

CHILLS_D3

CHILLS_D7

CHILLS_D7

COUGH_D0

COUGH_D0

COUGH_D3 +

+

COUGH_D7

+

- SHORTBREATH_D0

- +

SHORTBREATH_D3

+

+

+

CHEST_PAIN_D0

+

CHEST_PAIN_D3
CHEST_PAIN_D7
+

-

- + CHILLS_D0

-

CHILLS_D3
CHILLS_D7
+

COUGH_D0

+ COUGH_D3

COUGH_D3

+

COUGH_D7

COUGH_D7

DIZZINESS_D0

DIZZINESS_D0

DIZZINESS_D0

DIZZINESS_D3

DIZZINESS_D3

DIZZINESS_D3

DIZZINESS_D7

DIZZINESS_D7

DIZZINESS_D7

EARACHE_D0

EARACHE_D0

EARACHE_D0

+

EARACHE_D3

EARACHE_D3

EARACHE_D3

+

EARACHE_D7

EARACHE_D7

EARACHE_D7

EYEPAIN_D0

+

EYEPAIN_D0

+

EYEPAIN_D3

EYEPAIN_D3

EYEPAIN_D7

EYEPAIN_D7

EYEPAIN_D7

FATIGUE_D0

FATIGUE_D0

FATIGUE_D3 -

FATIGUE_D3

FATIGUE_D3

FATIGUE_D7

FATIGUE_D7

FATIGUE_D7

HEADACHE_D3

HEADACHE_D3

HEADACHE_D7

-

-

-

HOARSENESS_D3 HOARSENESS_D7
-

HOARSENESS_D0

-

- HOARSENESS_D3

-

-

-

-

-

-

HOARSENESS_D7

JOINTPAIN_D3

+ JOINTPAIN_D3

+

+

JOINTPAIN_D3

JOINTPAIN_D7

JOINTPAIN_D7

MUSCLEPAIN_D7
NAUSEA_D0

-

-

-

MUSCLEPAIN_D0

+

+ MUSCLEPAIN_D3

+ +

+ NAUSEA_D0

MUSCLEPAIN_D7
NAUSEA_D0

+
+

JOINTPAIN_D7

MUSCLEPAIN_D0
MUSCLEPAIN_D3

+

HOARSENESS_D3
JOINTPAIN_D0

+

+ +

HOARSENESS_D0

+

+

-

HEADACHE_D7

+

MUSCLEPAIN_D3

-

FATIGUE_D0

JOINTPAIN_D0

MUSCLEPAIN_D0

+

+ HEADACHE_D3

HOARSENESS_D7
-

+

HEADACHE_D0

+

HEADACHE_D7

HOARSENESS_D0

JOINTPAIN_D0

+

- HEADACHE_D0
+ +

+ +

+ EYEPAIN_D0

EYEPAIN_D3

HEADACHE_D0

+

SHORTBREATH_D7

CHEST_PAIN_D7

CHILLS_D0 -

1 2 3 4

DECREASEAPP_D7

SHORTBREATH_D3 +
CHEST_PAIN_D0 + +

-

+

MUSCLEPAIN_D7
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+

NAUSEA_D3

NAUSEA_D3

NAUSEA_D3

NAUSEA_D7

NAUSEA_D7

NAUSEA_D7

RUNNYNOSE_D0

+ +

RUNNYNOSE_D0

RUNNYNOSE_D3

- RUNNYNOSE_D3

RUNNYNOSE_D7
SNEEZING_D0 -

+
-

-

SORE_THROAT_D7

RUNNYNOSE_D0

-

RUNNYNOSE_D3

+

SNEEZING_D3
+

+

- RUNNYNOSE_D7

- SNEEZING_D0

SNEEZING_D7
SORE_THROAT_D3 -

+

RUNNYNOSE_D7

SNEEZING_D3
SORE_THROAT_D0

-

-

-

SNEEZING_D0

-

SNEEZING_D3

-

SNEEZING_D7

SNEEZING_D7

SORE_THROAT_D0

SORE_THROAT_D0

- SORE_THROAT_D3

SORE_THROAT_D3

SORE_THROAT_D7

SORE_THROAT_D7

+

**Symptoms vomiting, diarrhea, & abdominal pain were removed because no differences seen

Discussion
This is the first study to the author’s knowledge that analyzed individual symptom
scores through unsupervised machine learning. A majority of ILI symptom research
focuses on determining if a patient’s symptoms can distinguish influenza from the other
ILI viruses (Michiels, Thomas, Van Royen, & Coenen, 2011; Call, Vollenweider,
Hornung, Simel, & McKinney, 2005; Monto, Gravenstein, Elliott, Colopy, & Schweinle,
2000). We attempted to differentiate all the viruses based on symptom score, but the
technique was unable to predict virus type based on physical symptom scores. Some
differences in symptoms among virus types were anecdotally observed, but only one
cluster (cluster 3, fig 3) showed statistical significance. A larger sample size may reveal
more statistically sound differences.
In the literature, symptom data for viral prediction tends to be analyzed as either a
dichotomous response or sum of scores response (Treanor et al, 2000; Monto et al, 2000;
VanWormer, Sundaram, Meece, & Belongia, 2014). We used the individual symptom
scores at the initial visit and visit days 3 and 7 to provide the algorithm more data to
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analyze differences. For instance, if only a sum of scores was analyzed, the differences
in fever or cough may have been missed.
The use of unsupervised machine learning provides further evidence that physical
symptom experiences vary by person. This concept was reinforced by the results of the
second objective, which showed individuals experience symptoms differently based on
individual characteristics. For instance, the study showed that a younger population
seems to present with less intense symptoms for rhinovirus, or women present with more
intense upper respiratory symptoms for influenza A compared to men. Healthcare
providers need to take into account outside factors like environmental, biological, or
social that are influencing symptom severity for ILI.
Limitations
There are several limitations to this study. One major limitation of the analysis was
the limited availability of patient data. This study was a secondary analysis of previously
collected data; therefore, data quality could not be controlled. While the original dataset
had over 1500 patients with viral diagnosis, over half were missing symptom reported
visit data for the analysis period. Additionally, another 51 patients were eliminated from
the sample due to viral co-infections, which could have introduced bias. A more
controlled and larger data set would greatly improve the analysis of this data.
Because the population used for this study was military personnel and their families,
these results cannot be generalized to the general public as the military population is
unique. Additionally, data from the ‘no virus’ group was difficult to use for comparison
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because the patients in that group most likely had some kind of bacterial or viral illness
that could not identified using ARIC’s biological analysis techniques.
Another aspect of the study that may have limited the results is how symptom
severity was measured. The instrument used to capture symptom severity was created for
the purpose of this study, and not psychometrically evaluated although the scale was
derived from other published scales. Research on symptom experience and the findings
from this study’s second objective have shown symptoms are not just physical but may
be affected by other sociodemographic characteristics (Armstrong, 2003; Macintyre,
1993). The Symptom Management Theory by Dodd et al, indicates there are three
components to symptom presentation: symptom experience, symptom management
strategies, and patient outcomes. Additionally, domains outside of the individual, such as
a person’s environment, health history, and biopsychosocial perspective, influence
symptom perception. Because the instrument concentrated on physical symptoms, the
results could be biased because outside factors were unmeasured.
Future Research
As this was a novel approach of data analysis using a common unsupervised learning
method, k-means clustering, further analysis with more sophisticated clustering methods
should be performed. With the results of the secondary analysis demonstrating the
difference in symptom presentation by sex, age, ethnicity, future studies should look at
outside factors that may influence symptom presentation of ILI.
Unsupervised machine learning could become a proven technique to help identify
patterns in medical research. Its technique could open new avenues of patient data
44

analysis and may reveal knowledge and factors that may not be obvious using traditional
statistical approaches. The use of it in the medical world needs to increase to further the
knowledge and provide better care for the patients.
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Chapter 3:
Clinical characteristics of strain specific human coronavirus among adolescents and
adults
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Abstract
The increase use of diagnostic tests for influenza-like illnesses has revealed the
symptomology of human coronaviruses can be more severe than previously understood.
The clinical presentation between the four common human coronavirus strains varies in
severity, especially among gastrointestinal symptoms.
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Introduction
Coronaviruses (CoV) are RNA viruses that are ubiquitous in mammals, ranging
from bats to humans. Four human coronaviruses have been described with increasing
frequency in humans, although human infection with animal coronaviruses does
occasionally occur, sometimes with drastic consequences as with the SARS and MERS
outbreaks. Despite the publicity and high case fatality rate of those outbreaks, circulation
of the human coronaviruses (HKU1, OC43, NL62 and 229E) is worldwide and infection
in humans is common1-5. As with human rhinoviruses, coronavirus were traditionally
difficult to diagnose and were generally thought to cause uncomplicated upper respiratory
tract infections (URI). With the increasing use of rapid diagnostic tests for a wide range
of respiratory pathogens, including human coronaviruses (hCoV), emerging data have
demonstrated that human coronaviruses can cause more significant illness than initially
thought6,7. There are very few data on whether unique type-specific clinical syndromes
might occur. Using a prospective cohort study of otherwise healthy adolescents and
adults with influenza-like illness, we sought to describe the similarities and differences in
clinical presentation of hCoV infections.
Methods
The Acute Respiratory Infection Consortium (ARIC) was established in July 2009
as a multi-site clinical research network to study ILI among otherwise healthy military
personnel and their beneficiaries. The aim of ARIC was to describe the natural history of
ILI among healthy people, through an observational/ longitudinal cohort study to
determine the etiology, epidemiology, and clinical characteristics of ILI at five US-based
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military treatment facilities across the United States. A secondary analysis of their data
symptom severity data from patients with diagnosed coronavirus was performed. ARIC
methods for data collection have previously been reported15, but below is a summary of
the methods utilized for ARIC’s prospective study.
From 2009-2014 otherwise healthy subjects aged 0-65 who presented to one of
the five military clinics within 72 h of ILI symptom were enrolled. ILI was defined as
having a fever (temperature over 100.4F) with at least one of the following respiratory
symptoms: cough, shortness of breath, sputum production, chest pain and/or sore throat.
People with a history of diabetes (type 1 and 2), COPD, uncontrolled asthma,
immunodeficiency, and/or chronic neuromuscular, cardiac, renal disease were excluded.
From this cohort, we identified participants ages 13-65 who had laboratory confirmed
coronavirus only by excluding those cases with a co-detection of another respiratory
virus.
Demographic information and clinical symptoms were collected by interview at
enrollment. A nasopharyngeal specimen was collected for virus identification.
Participants returned to clinic at days 3±1, 7±2, and 28±7 for collection of symptom data
and additional tests.
Additionally, clinical symptom severity was recorded by the participants utilizing
a 7-day symptom diary, as previously described. Briefly, symptom severity was
characterized by the sum of 4-point symptom scores in four categories: upper respiratory
(earache, runny nose, sore throat, and sneezing), lower respiratory (cough, breathing
difficulty, hoarseness, and chest pain), systemic (muscle ache, fatigue, headache, and
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chills), gastrointestinal (nausea, vomiting, and diarrhea), and total severity (the above 15
symptoms).
The nasopharyngeal swabs underwent multiplex testing at the Naval Health
Research Center (San Diego, CA, USA) for detection of the following viral respiratory
pathogens: influenza virus, adenoviruses, respiratory syncytial virus, parainfluenza virus,
and human metapneumovirus and human CoVs. Participants aged 13-65 years old with
corona virus types HKU1, OC43, NL63, and 229 E without co-detection of another virus
were included in the final analysis.
Statistical Analysis
Descriptive statistics were used to identify the differences in demographics,
geographic location, and potential risk factors by corona virus type. Severity of clinical
symptoms were assessed by system composite score and total score for each strain type.
Fischer exact test were utilized for categorical variables, and Kruskal-Wallis test were
used to examine clinical symptoms for the different corona strains. Analyses were
performed using SPSS software, version 22 (IBM corporation).
The study was approved by the Infectious Disease Institutional Review Board of
the Uniformed Services University of Health Sciences (IDCRP-045) and written
informed consent was obtained.
Results
Between 2009 and 2014, CoV was detected in approximately 12% of the enrolled
ARIC participants. Of the 111 positive participants, 29 (26.1%) were excluded because
they were under the age of 13 years (n=15) or had a viral co-detection (n=14). The 82
56

remaining cases were included for analysis and sub-categorized into the four different
types of CoVs. The 82 cases had a mean age of 28 years with a range of 13 years-49
years, and included 71 (87%) adults, 42 (51%) females, and 69 (84%) active duty
military members. The study population ethnicity was 60% Caucasian, 24% AfricanAmerican, 5% Asian, and 11% other. Among the 82 cases, 23 (28%) had 229E, 18
(22%) had NL63, 28 (34%) had OC43, and 13 (16%) had HKU1 (see figure 1). The
prevalence of the type of CoV did not differ by demographic characteristics, with the
exception of the 2010-2011 flu season, which had fewer cases of diagnosed CoV
compared to the other seasons (p=0.046).

Adolescents (13-20years)

229E

NL63

OC43

Adults (age 21-65 years)

229E

HKU1

NL63

OC43

HKU1

Figure 1: Distribution coronavirus strain by age
Participants with HKU1 had a trend to higher visit 1 composite scores for
gastrointestinal symptoms compared to the other virus types, but were not statistically
significant. The majority of participants (76%) reported persistent symptoms through day
7. The composite scores for upper respiratory, lower respiratory, systemic,
gastrointestinal, and total symptoms peaked on days 3 and 4 and tended to decrease
thereafter (figure 2). HKU1 had statistically significant difference in composite GI
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symptom score on day 4 (p=0.05), compared to the other strain types. No other
statistically significant symptom composite scores were noted, although higher systemic
symptom scores for HKU1 approached significance on days 3 and 4 compared to the
other virus types.

Figure 2: Symptom Severity Participant Diary
*indicates approaching statistical significance and **represents statistical significance
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Discussion
This study was the first study to compare the epidemiology and symptom severity
of the four common human coronavirus strains in an otherwise healthy population. The
longitudinal design of the study allowed for the prospective capture of self-report
symptom severity scores utilizing a standard symptom severity instrument. In order to
ensure symptoms were attributable to CoVs, all cases of viral co-detection were
excluded. Subjects under 13 years old were eliminated because parental symptom
reporting occurred in younger children and is difficult to compare to self-reported
symptoms.
Few studies exist that describe severity differences between the CoV’s in young
health adults, though several have been published in children5,6,8-10, or older adults with
co-morbidities11-13. Lau and colleagues published the results of a prospective cohort
study of hospitalized children and adults, though the mean age was between 2 and 9 years
of age, depending on the CoV type1. Dare et al published a similar prospective cohort of
mixed inpatient (64, 78%) and outpatient (18, 22%) children (34, 41%) and adults (48,
59%) and found no difference in severity between the four types3. A study of mixed
children and adults done by Gaunt and colleagues had high rates of co-detection which
were not removed from study data14. Our study of young healthy adolescents and adults
with no co-detections found that coronavirus 229E was more prevalent in adolescents,
and OC43 more so in adults. Additionally, it was noted that the HKU1 strain had higher
gastrointestinal symptom severity when compared to the other virus types on days 3 and
4. HKU1 also had a trend toward more severe systemic symptoms with lingering lower
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respiratory composite scores compared to the other three virus types. Previous literature
has noted that HKU1 is associated with gastrointestinal symptoms than the other three
viruses, but it has not been associated with more prolonged lower respiratory tract and
systemic symptoms16.
Although the strengths of this study are the prospective data collection with
symptoms diary validation, multiplex testing, and 5 year time-period, it is a secondary
review of a large database not designed specifically to detail CoVs. Additionally, the
symptom severity diary was developed for the purpose of the original study, and was not
a validated instrument. Our scale is nearly identical to that used by Hayden et al for ILI
symptom severity in neuramindase inhibitor trials, although there is no agreed upon,
validated scale for ILI symptom severity. The small sample size (n=82) may have
prevented us from making further associations with the coronaviruses and clinical
outcomes, although it is one of the largest human CoV cohorts in healthy patients to-date.
Lastly, subjects were only those who sought medical care, so it cannot be assumed that it
represents the entire spectrum of illness from asymptomatic through severe presentations
In summary we describe the epidemiology of symptoms in healthy adolescents
and young adults in whom one of the four common species of coronaviruses was
detected. Although not often attributed to CoVs, intestinal symptoms were once again
described, especially with HKU-1, and trends toward differential severity and duration
were observed.

Coronaviruses should be considered as a potential cause of ILI, and

future research on risk factors and prevention, as well as surveillance for the potential of
less common CoVs is needed.
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Chapter 4:
A Critique: The Canadian Acute Respiratory Illness and Flu Scale
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Abstract
Acute respiratory illness is the most common clinical childhood illness globally,
and there are few instruments available that measure acute respiratory illness severity,
especially in children. An instrument created to fulfill this gap is the Canadian Acute
Respiratory Illness and Flu Scale (CARIFS). The CARIFS is an instrument with reported
psychometric testing that measures acute respiratory tract illness disease severity. This
article is a review of the psychometric properties of the Canadian Acute Respiratory
Illness and Flu Scale with a focus on its strengths and limitations.
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Introduction
Acute respiratory illness (ARI) is the most common clinical childhood illness
globally. In 2010, there were approximately 15 million hospital admissions globally of
children with acute lower respiratory tract infection (Nair et al., 2013). It is estimated the
cost associated with acute respiratory illnesses in the US is over 12 billion dollars
annually, and yet there are a limited number of instruments available that assess and
measure acute respiratory illness severity, especially in children (Jacobs et al., 2000).
One of the few available instruments available is the Canadian Acute Respiratory Illness
and Flu Scale.
Background
The Canadian Acute Respiratory Illness and Flu Scale (CARIFS) was originally
developed for use in research to measure ARI disease severity among children (range 0 to
12 years) by capturing health care professionals’ and parents’ concerns with ARI. While
developed for research purposes, there is evidence it has been used by clinicians in
practice (Fischer, 2014). Overall, the instrument uses a list of symptoms to measure the
disease severity of ARI.
Origin of Instrument
The CARIFS was initially based upon the Kirshner and Guryatt framework for
assessing health indices (1985). The development of the instrument began with item
selection and face validity to reduce items as well as generate new items. Content for an
initial 25 items was generated from the items of 13 other instruments (Hayden et al.,
1997; Hayden et al., 1996; Barker et al., 1998; Englund et al., 1994; Hall et al., 1987;
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Morley et al., 1991; Landgraf et al., 1996; Young et al., 1995; Msall et al., 1994;
McCarthy et al., 1982; Pollack et al., 1996; Stein et al., 1990; Walker & Greene, 1991).
While these instruments were used to extrapolate items, several had no published
statistics on validity.
Following the generation of 25 items, face validity was determined using three
general pediatricians and 23 parents of children with ARI. As a reminder to readers, face
validity is not a psychometric test; it is a subjective form of evaluation (Waltz, Strickland
& Lenz, 2016). In this case, the pediatricians and parents evaluated items by ranking the
relevance of the initial 25 items that were presented to them, each on separate cards. They
had the option to remove cards that had items believed to be irrelevant as well as to
generate up to five new items that they regarded as important. That evaluation led to the
reduction of the 25 items to 17. Only one item was added to the list (clinginess) resulting
in an instrument with a total of 18 items. Next, the items were subjectively grouped into
three dimensions by the instrument authors. The resulting dimensions included a)
symptoms (e.g., cough, fever), b) function (e.g., not playing well, not interested), and c)
parental impact (needing extra care, clinginess) (Jacobs et al., 2001). There are no
published criteria available to determine what was used to group the individual items into
these three dimensions.
Description of Instrument
The current version of the CARIFS contains the 18 items within the three
dimensions described above. The instrument is to be completed by the parent of a child
with ARI. There is no recommended time limit to be imposed for completing the
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instrument. In fact, over time, there is evidence that different researchers have used
different timeframes for instrument completion (Shepperd, et al., 2004; Fischer et al.,
2014; Vohra et al., 2008; Whitley et al., 2001).
Scoring
The 18 items are scored on a four-point ordinal scale with 0= no problem, 1=
minor problem, 2= moderate problem, 3= major problem, and not applicable= no score.
A total score is then calculated by summing the individual item scores, ranging from 0
(best possible health) to 54 (worst possible health). If any item is marked as ‘not
applicable’ then a mean score is calculated based upon the items that were answered.
That mean score is then multiplied by 18 to obtain a total score (Jacobs et al., 2001). No
cut-off scores have been reported in the literature for clinical or research for determining
ARI disease severity; therefore, the instrument does not have norms and would not be
considered standardized for clinical purposes (Waltz, et al., 2016). Finally, a parent
global health assessment, a 10 cm visual analog scale (VAS), is placed underneath the
CARIFS items with instructions to mark the perception of the child’s health on the line
with a single mark from best to worst possible health (Jacobs et al., 2001).
Psychometric Testing
The first psychometric testing for the CARIFS (diary version) was performed in
three Canadian cities, Halifax, Calgary, and Toronto, during the winter of 1998. The
parents of 220 otherwise healthy children, aged 0 to 12 years, with ARI symptoms in the
previous 72 hours were enrolled in the study; 206 completed data collection. Inclusion
criteria were a) a diagnosis of ARI with criteria for ARI being a fever above 38C, in the
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past 72 hours, b) at least one upper respiratory symptom (e.g., nasal congestion, cough,
sore throat), and c) at least one systemic symptom (e. g., fatigue, headache). A diary
format was designed for this study. The diary contained sixteen individual CARIFS
instrument sheets. Each sheet was to be completed twice daily for days 1-7 and once
daily on days 10 and 14 by the parents. No recommended time frame for completing the
score sheets could be located in the published literature. Therefore, some parents may
have completed each sheet at the end of each day, while others may have completed all
16 sheets on the last day of data collection.
At the enrollment visit, the child’s axillary temperature was recorded, and their
parents rated the ARI disease severity by completing the first CARIFS instrument diary
entry. The parents then completed the parent global health assessment (VAS 10 cm) part
of the CARIFS for the child’s current state of health (Jacobs et al., 2001). Additional
testing involved physicians and nurses completing the CARIFS as well as other
instruments to compare ARI symptoms between instruments.
CARIFS Reliability
Determining reliability is a necessary process every time instruments are
administered (Waltz, et al., 2016). Initially, the CARIFS reliability was assessed using
test-retest to determine its stability over time. This was determined by comparing
instrument scores completed by the same person at two different times on the second day
after enrollment. The morning score was compared to the evening score with a resulting
correlation coefficient of 0.808 indicating acceptable reliability (Mayo, 2015).
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Internal consistency is an evaluation of reliability and is determined by
calculating a Cronbach alpha. This can be done for a total score as well as subscale
(dimension) scores. The Cronbach alpha is a statistical test that determines if all items in
a group of items (be it the entire instrument or a subscale) are measuring the same
concept. A score of 1.0 would equate to perfect internal consistency reliability, at least
0.90 for clinical purposes, and 0.70-0.80 for research purposes (Mayo, 2015; Waltz, et
al., 2017). Initial testing of the CARIFS was completed in a Canadian population
resulting in an acceptable Cronbach alpha of 0.89 for the total score only. Using similar
psychometric testing on the CARIFS, but with parents of 178 children with ARI located
in the United Kingdom (UK), total score internal consistency was again acceptable at
0.85. However, somewhat lower test results were obtained for the symptom dimension
(0.54), function dimension (0.77), and parental impact dimension (0.70).
Validity
Determining if the CARIFS produced valid data was accomplished through
construct validity and responsiveness testing. Construct validity identifies how well the
instrument items measure what they are operationally defined to measure. A number of
tests of validity such as convergent validity testing can be used to determine construct
validity (Waltz, et al., 2016).
Initial construct validity was determined for the CARIFS by using convergent
validity testing. As part of this testing, physicians and nurses were asked to simply score
the severity of the child’s illness as mild, moderate or severe. Additionally, the nurses
scored the child’s health status by completing an adapted version of the Yale Observation
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Scale (YOS). The YOS is designed to measure severity of illness in children up to three
years old with fever in the emergency room department (McCarthy et al., 1982; Bang &
Chaturvedi, 2009). Then the total parent CARIFS scores were compared with the a)
parent VAS scores (r=0.52), b) YOS scores (r=0.48), c) child axillary temperatures at
time being seen by providers (r=.29), and d) the simple assessment classifications from
those physicians (r=0.36) and nurses (r=0.44). One explanation that has been offered for
the weak correlation between the CARIFS scores and the axillary temperatures at
enrollment (r=0.29), was that only 59% of the participants had a fever at enrollment.
Shepperd et al. also approached assessing construct validity similarly except a VAS was
used for physician and nurse assessments in addition to the parent VAS score. The
Spearman coefficients were calculated between the CARIFS score and VAS scores from
the general practitioner (r=0.13), nurse (r=0.35), and parent (r=0.40).
Sensitivity, an important concept in the clinical arena when caring for and treating
patients, is defined as the ability of an instrument to detect change over time within the
same patient. The smaller the amount of change an instrument can pick up, the more
sensitive the instrument (Waltz, 2016). For the CARIFS it was hypothesized that the
child’s severity of illness would diminish over time based on the typical course of ARI,
thereby setting up the perfect opportunity to measure responsiveness to change. Using an
effect size approach, the change in total CARIFS scores were determined for 1) time of
enrollment, 2) 8 hours post enrollment, and 3) day 3 of illness. As background, an effect
size score above 0.5 indicates moderate change and above 0.8 indicates large change
(Kazis, 1989). At 8 hours post enrollment the effect size was 0.5 and at day 3 of illness it
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was 1.6, indicating that the CARIFS is very responsive to improvement over time. Due
to few children’s health declining over the course of the illness, the instrument could not
be assessed for responsiveness to decline.
Instrument Strengths and Limitations
The primary strength of the CARIFS is that it was built upon the Kirshner and
Guryatt process framework for assessing health indices (1985). Therefore, the
methodological framework undertaken included item selection, scaling and reduction, as
well as, determining the instrument’s reliability, validity and sensitivity. Additionally,
while not a true test of validity, face validity was determined by a large number of
parents (N=23). There are several limitations to the CARIFS that should be noted by
clinicians and researchers prior to utilizing the instrument.
Administration and Scoring
The instructions for administration and scoring of the CARIFS do not appear to
have been standardized. An instrument should have consistent and defined
administration guidelines, such as specifications and conditions (Waltz, Strickland, Lenz,
2016). In the literature, there are different versions of the administration process for the
CARIFS, ranging from completing the instrument once a day for two weeks to just once
during an emergency room visit. In fact, some publications on the CARIFS provided no
information regarding how the instrument was administered (Whitley et al., 2001; Vohra
et al., 2007; Fischer et al., 2014). Because the CARIFS does not have standard
instructions for administration, users should be cautious when comparing results among
referent groups (Waltz, Strickland, Lenz, 2017).
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As discussed earlier, a total score for the CARIFS is obtained by summing all
items, and a procedure for addressing missing data has been described above. However,
established norms have not been located in the literature. While the CARIFS was created
to measure disease severity of ARI, there are no identified norms for mild, moderate, or
severe ARI disease severity. Without the established norms to classify the severity of
ARI, it is difficult to interpret scores for clinical or research purposes.
Reliability Issues
Several forms of reliability testing were performed on the CARIFS. An
instrument is considered reliable if it consistently measures the same attribute repeatedly
over time. The CARIFS had several forms of reliability testing performed, as mentioned
above, but the testing was not performed in a controlled or consistent manner. Instrument
stability was performed using test-retest approaches. While appropriate testing, the time
frames between testing were vague. Morning and evening testing (no time intervals)
makes it is difficult to know if the instrument is indeed stable for any specified time
interval. Additionally, it is unknown if any activities may have occurred during the time
intervals that may have influenced the CARIFS score, e.g., the child was given a cough
suppressant. In order to estimate test-retest reliability the CARIFS should have been
administered at defined times and under standard conditions. But due to the lack of
specificity in time intervals and conditions, users should proceed with caution and not
assume strong instrument stability.
Internal consistency. While an acceptable total score internal consistency has
been determined for clinical and research purposes, it has not been established for clinical
74

purposes for the three dimensions (symptoms, function, and parental impact).
Additionally, because the alpha coefficient was so high, 0.89, it could be assumed that the
instrument measures just one attribute (McCrae, 2011); thereby making the subscales not
relevant to the measure. Prior to using the three dimensions in clinical decision-making,
the internal consistency for each one should be established at higher levels. Further
reliability testing should also include interrater reliability for provider groups and
parental groups.
Validity Issues
While several forms of validity testing were performed on the CARIFS, questions
of validity remain. As a reminder, validity refers to the extent an instrument measures
what it proposes to examine. When validity is assessed, the instrument is not what is
being evaluated, but rather the scores obtained from instrument. The CARIFS was
developed using items from other instruments and the opinions of several parents and
physicians, making validity testing extremely important.
The stated objective of the CARIFS is to measure disease severity in children
with ARI. However, the instrument scoring appears to be more focused on the duration of
illness. Concern exists regarding the ambiguity of the instrument: does it indeed measure
disease severity or duration of illness? It may be beneficial to utilize subject matter
experts with theoretical knowledge to assist in the identification of the instrument
construct and face validity. Additional psychometric testing might address item-content
validity in order to determine if each item is a measure of the content domain (Waltz, et
al, 2017).
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While issues of item-level validity exist, there may also be issues surrounding the
instrument domains as well. Because criteria for determining the placement of the 18
items into the domains are not provided, use of the domain scores for clinical decisionmaking or research purposes should be made with caution. Factor analysis, a technique
used to examine patterns of variance among items might be a first step in determining the
dimensions of the CARIFS.
As described above, CARIFS convergent validity was assessed using a modified
version the Yale Observation Scale (YOS). However, there was no indication of how the
YOS was adapted or if any psychometric testing had been performed on the adapted scale
prior to its use for convergent validity testing. If this modified version did not have
validity itself, it would not serve as an appropriate measure to determine validity for the
CARIFS. Additionally, there were important differences in the correlation of the overall
CARIFS scores to the different provider assessment scores as well as to the axillary
temperatures. Further work in establishing consistency in the instrument’s validity would
be recommended.
Finally, a majority of the CARIFS items focus on symptoms the child is
experiencing because of ARI. The severity of symptoms of any disease can be
influenced by psychological or situational factors, which the CARIFS does not measure.
Several symptom-based theories, including University of California San Francisco
(UCSF) Symptom Management model identify that symptoms are more than a
physiological response to illness (Dodd et al., 2001). Including items such as
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environmental, sociocultural, and functional health factors may change how the CARIFS
would measure disease severity thereby improving validity of the data it produces.
Conclusions
Nearly every child will experience an acute respiratory illness (Simones et al,
2006). Therefore, a comprehensive way to measure the severity of that illness should
exist. Instruments that measure disease severity in children with ARI are limited. The
creation of the CARIFS provides an opportunity to objectively measure disease severity
for both clinical care and research but should be used with caution, especially in clinical
decision-making.
Instrument limitations identified in this paper are based upon questionable
reliability and validity testing, therefore, further testing is recommended. It would be
important to repeat reliability testing using specific time parameters for administering the
instrument. Furthermore, treatments during testing procedures should be documented,
and their effects considered part of testing the reliability of the CARIFS. To improve
validity testing, domains should be established based on factor analysis. Including the
measurement of environmental, sociocultural, and functional health factors in any
revisions of the instrument may provide a more complete picture of disease severity of
childhood ARI, and potentially provide an improved instrument for measuring symptoms
important to parents and clinical nurse specialists.
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Chapter 5
This chapter synthesizes the information from the three aims addressed in this
study, and the implications for nurses, education, and future research.
Aims
This dissertation concentrated on three different research questions, each
addressed in a separate paper formatted for potential publication. The aims were:
1. Identify if symptom presentation over the course of influenza-like illness (ILI)
can predict virus type in an otherwise healthy military population using
unsupervised machine learning; Identify sub-populations with similar symptom
experience.
2. Describe the strain-specific clinical characteristics of coronavirus among an
otherwise healthy US military population.
3. Examine the psychometric properties of one of the few validated instruments
examining disease severity of ILI: the Canadian Acute Respiratory Illness and Flu
Scale (CARIFS).
Research Question 1: ILI and Machine Learning
I performed a secondary analysis of ILI symptomatology and virus type from a
prospective study conducted by ARIC. The first objective was to identify if unsupervised
learning could predict virus type based on physical symptom presentation. The second
objective was to determine if I could identify subpopulations with similar symptom
experience controlling for virus type.
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The symptom severity data from visits on days one, three and seven were
analyzed with a novel approach called unsupervised learning by k-means clustering. The
clustering method identifies related cases with similar symptoms and clusters the cases
together. The symptom scores reported were analyzed individually, and not by a sum of
scores to provide more flexibility in cluster creation. The distribution of viral diagnosis
was not equal. I observed the highest number of participants in our sub sample as not
having a virus diagnosis (289), with the second highest diagnosis being influenza A
(107), and the lowest being bocavirus (0).
Clustering was run with k values (number of clusters) ranging from 5 to 10. After
review of the initial analysis, k=7 appeared to have the most favorable results. Chi
square analysis showed that only one cluster had a statistically significant difference
(p<.000) with a high coronavirus percentage (17.3%) present in the cluster when
compared to the rest of the population. With only one cluster showing statistically
significant results, the approach was unable to predict virus type based on individual
symptom presentation.
The second objective analyzed only patient data for those diagnosed with
influenza A, coronavirus, and rhinovirus because they had the largest number of
patients. Three separate analyses were run, one for each viral types. The patients were
clustered by symptom severity scores, as above, and then their demographic data was
compared to against the populations to determine if any clusters represented a specific
type of group expression. The demographic data (attributes) included: sex, military
status, age, BMI, smoking history, and ethnicity. Due to varying sample sizes the
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following virus cohorts were clustered with k sets: influenza A (n=107) k=5, rhinovirus
(n=101) k=5, and coronavirus (51), k=4.
Fischer’s exact tests were performed on the groups with identified different
attributes. Bonferroni post-hoc analyses were performed to identify which attributes
within the clusters were responsible for causing the differences. The goal was to identify
if certain attributes caused a group to cluster together. Analyses revealed each virus had
at least one symptom cluster with a statistically significant difference based on patient
attributes. Five out of the six attributes in the rhinovirus data showed statistically
significant differences (age, BMI, sex, smoking status, and military status). The
coronavirus clusters only showed the attribute of sex being statistically different amongst
the clusters. The clustered data for influenza A revealed statistically significant
differences of the sex and military status attributes.
This research was conducted on a uniform population consisting of otherwise
healthy military members, dependents, and retirees. The results of this study can be used
to help further understand the characteristics of ILIs in this unique population. A strength
of this research was it utilized a novel approach to analyze symptom data for ILI, and
identified unique population attributes that may affect symptom presentation.
Research Question 2: Coronavirus
Strain specific differences in the four common human coronaviruses (HKU1,
NL63, OC43, 229E) have not been well described in the literature. Utilizing data over a
five year period from a prospective ILI study by ARIC the similarities and differences in
clinical human coronavirus infections in an otherwise healthy adolescent and adult
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military population were described. Demographic, geographic, and potential risk factors
were analyzed by strain type using descriptive statistics. The symptom severity data for
analysis was obtained from the symptom diaries the patients filled out on a daily
basis. Symptom severity for days 1 through 7 were analyzed by system composite score
and total score for each strain type. Data was analyzed by either Fischer’s exact test (for
categorical variables) or Kruskal-Wallis (for continuous variables) to examine clinical
symptoms for the different corona strains.
Descriptive analysis showed coronavirus strain 229E was more common in the
adolescent population, while OC43 more so in adults. Demographic attributes were not
statistically different among the coronavirus strains. Analysis of the system composite
scores showed a peak in symptom severity at days 3 and 4, and tended to decrease
thereafter. The corona strain, HKU1, did show a statistically significant difference in
gastrointestinal (GI) composite scores on day 4 being higher than the other strains, and
trended higher through the course of illness when compared to the other strains. The
majority of participants (76%) reported lingering symptoms through day 7 of illness.
The strengths of this study was characterizing the epidemiology of symptoms of
the four different coronavirus strains in an otherwise healthy adolescent and adult
military population. Additionally, this study noted that GI symptoms occur with human
coronaviruses, an important finding as most literature on ILI tends to overlook GI
symptoms. With the recent outbreaks of Severe Acute Respiratory Syndrome (SARS) and
Middle East Respiratory Syndrome (MERS), which are more severe/ less common forms
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of human coronaviruses, it is important to understand the epidemiology of all forms of
human coronaviruses.
Research Question 3: CARIFS Critique
ILI is the most common diagnosis among children globally, but there are a very
limited number of scales to capture ILI disease severity. The Canadian Acute
Respiratory Illness and Flu Scale (CARIFS) is one of the very few validated scales
available for research and clinics to determine ILI disease severity in children. A
psychometric critique of the CARIFS was performed to evaluate its strengths and
weaknesses.
Upon completion of the CARIFS critique, many strengths and limitations were
noted. Some of its strengths include it being one of the few validated instruments to
measure ILI disease severity and some approaches to validity and reliability testing were
performed in the Canadian and United Kingdom populations. The scale also had several
limitations such as, limited content validity testing, poor administration and scoring
instructions, and the concern that contextual information is not captured. Some
recommendations for the CARIFS would be to perform factor analysis to confirm the
questions are truly measuring the outcome. Additionally, consider the development of
another version of CARIFS utilizing the theoretical underpinnings of the Symptom
Management Theory.
Implications for Nursing Practice
The results from this study could change how some nurses view ILI
symptomatology. The knowledge that patient attributes affect symptom presentation
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could change how they approach care for a patient. Additionally, the knowledge of
clinical manifestation of the common coronavirus will give them more confidence in
caring for people with those common strains.
Most importantly, nurses should be aware of the instruments they use for patient
care, patient evaluations, and research. The psychometric critique of the CARIFS
showed how an instrument that has been validated can still have numerous limitations. It
is important nurses understand how instruments are made and the limitations they may
have. If nurses are using instruments to influence change in nursing practice through
evidence based practice research, they should perform a psychometric critique of their
instruments.
Nurses are now using big data sets, such as patient charts or surveys, to answer
questions on patient outcomes. The National Institute of Nursing Research (NINR) has
recently added symptom science it its list of innovative questions. They seek to fund
studies that address current questions in symptom science such as care models and how
outside factors influence symptom management. The NINR has also focused on funding
studies that can advance nursing research through data science. There are large and
complex datasets available that are potentially rich sources for answering important
research questions. The use of unsupervised machine learning is a unique approach to
analyze complex datasets. Recent nursing literature has started to note the benefit of
using unsupervised machine learning to data mine the large amounts of data that is
collected with patient care (Berger & Berger, 2004; Goodwin, VanDyne, Lin, & Talbert,
2003; Meyfroidt, Guiza, Ramon, & Bruynooghe, 2009).
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Implications for Future Research
This study showed how different ILI viruses can cause different symptom
presentations in the population. Although, the more common approach of unsupervised
learning method was used, k-means clustering, further analysis with more sophisticated
clustering methods should be performed. Understanding how different clustering
methods may be able to differentiate virus type based on symptoms presentation may
provide important knowledge about the strengths of different clustering techniques as
applied to symptom science. Additionally, examining the data with principal component
analysis or standard regression to compare findings against unsupervised learning would
help further inform the utility of this analytic approach compared to the more traditional
ones. Also, comparing the analysis of the symptom score data in a variety of ways, such
as the change in symptom score by day or the sum of scores to individual score, may
limit the number of variables the unsupervised learning algorithm needs to consider and
may produce different results. With the results of the secondary analysis demonstrating
the difference in symptom presentation by sex and age, future studies should look at
outside factors that may influence symptom presentation.
Future research in the field of symptoms should consider the development of
instruments capturing symptom data by utilizing the theoretical underpinnings of the
symptom management theory. The theory takes all aspects (social, environmental,
biological) of symptom presentation into account. The critique of the CARIFS showed
the importance of collecting contextual information in addition to physical data.
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Most the viruses captured in this dataset have more than one strain that causes the
illness. The number of patients with complete data though limited the analysis that could
be performed on the different strains. The small analysis on the four common human
strains of coronavirus showed there are differences between symptom
presentations. Future research should focus on understanding the clinical characteristics
of the different strains of viruses to further our knowledge on symptom experience.
Personal Future Research
As a nurse researcher I plan to continue to expand my knowledge and research in
the field of symptomatology. Presently, I will continue working with the ARIC dataset
utilizing the unsupervised learning technique to expand my knowledge on this type of
data mining and knowledge of symptom presentation. I plan to use different machine
learning approaches to have a better understanding of which approach works better for
the type of data I am working with. I will further investigate how different attributes lead
to different symptom expression in patients. I will also pursue research comparing the
unsupervised learning technique and traditional statistical approaches, like regression, to
understand the similarities and differences between the approaches.
For my future research, I plan to use this knowledge and integrate the study of
symptomatology with genetics. I would like to study how a person’s genetics can
influence symptom presentation, and determine if symptoms can be prevented or ‘turned
off.’ Additionally, I plan to advocate the need for nurses to understand the science of
symptomatology. Nursing programs need to focus on the symptom management theory,
so nurses have a baseline knowledge of symptomatology they can grow, and teach their
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patients as well. Nurses are currently the main group of healthcare professionals focusing
on the study of symptomatology, I plan to embrace that, and continue with pushing our
profession forward in this field, so nurses are considered the experts on symptom
management.
Implications for Nursing Education
Nurses spend more direct and indirect time with patients than doctors. They track
and follow the care of a patient closely, and are typically the first to see a change in a
patient’s status (DeLucia, Ott, & Palmieri, 2009). It is important for nurses to be able to
recognize a change in symptom severity and how different attributes may affect symptom
presentation. A slight change in a patient’s symptom presentation can be the beginning
of a downward spiral for them. The quality of nursing care directly affects patient
outcomes.
This research demonstrates the importance for nurses to be educated in the field
of symptomatology. Nursing programs should have some course content focusing on the
symptom management theory in order for nurses to understand the complex structure of
symptom development and presentation. Symptoms typically bring attention to an
underlying problem. As nurses, we have to have an understanding of these symptoms
that may be warning signs to a potentially lethal problem. Nurses have to look at the
overall picture according to the symptom management theory instead of just the symptom
itself.
Additionally, nurses should be able to explain the importance of symptom
presentation to patients. Patients should be taught about warning signs for resurgence of
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conditions or the meaning behind some symptoms experienced. Nurses need to convey
to patients to not necessarily treat a symptom of a chronic condition, but understand why
it is happening, so treatment of the underlying problem can be addressed and not the
symptom.
Conclusion
To summarize, symptomatology is a new field of study that is progressing
rapidly. Medical professionals used to treat an individual symptom instead of treating the
entire person. For example, if you had pain, you were prescribed an analgesic instead of
determining an underlying problem such as depression, may be the etiology of the
presenting pain syndrome. Because current research has shown that symptoms are
multiplicative, the entire patient, biological, social, environmental, needs to be examined,
not just the area of interest.
The three aims of this research have a common theme about understanding the
meaning of symptom presentation. As discussed in symptom management theory, to
truly understand and manage the treatment of symptoms more than just the physical
symptom needs to be considered. By critiquing the CARIFS, it brought my attention to
most scales used to examine symptom severity in patients with ILI do not focus on
outside factors. By performing the clustering on physical symptoms only by virus type, it
proved that unique attributes affect symptom presentation. Additionally, the analysis of
the four common strains of coronavirus showed each strain can have a different way of
presenting symptoms. This may also be true of other viruses since most of the viruses in
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this study had multiple strains. Understanding symptom presentation in different strains
may help with treatment management.
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